The pill, an antiviral drug called molnupiravir, was tested against a placebo in people at high risk of developing severe disease. Of the 377 people who got the placebo, 14.1 percent, or 53 ...

Molnupiravir was given to people twice a day, for five days at home, while they had the Omicron variant of Covid. Those chosen were at a higher risk of death or hospitalisation from Covid due to ...

Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.

Aside from Paxlovid, one alternative oral antiviral treatment is known as molnupiravir. There's also remdesivir, which is administered intravenously. The CDC says Paxlovid and remdesivir are the ...

In a recent study published in The Lancet Microbe, researchers investigated the effects of molnupiravir on the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in ...

Pfizer’s Paxlovid and Merck & Co’s Molnupiravir are two oral antiviral treatments authorised for patients with mild to moderate COVID-19 symptoms at a high risk of developing severe illness.

Only about 5.3% of people with COVID-19 had been treated with an outpatient antiviral, such as nirmatrelvir-ritonavir (Paxlovid), molnupiravir (Lagevrio), or remdesivir (Veklury). In contrast ...

With changing recommendations and multiple seasonal viruses to contend with, here’s your simple guide to the 2024-2025 cold and flu season and when to call your doctor.

The Microbiology Society is pleased to announce the winners of our 2025 Prizes, which will be awarded at Society’s Annual Conference 2025 in Liverpool from 31 March – 3 April, where the winners will ...

Total Worldwide Sales Were $16.7 Billion, an Increase of 4% From Third Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 7% KEYTRUDA Sales Grew 17% to $7.4 Billion; Excluding the ...

A Cranbourne North couple are desperate to bring their pet cat back home fully healthy after he was diagnosed with […] ...